Huabing Yang

发表

Clinical safety of induced CTL infusion through recombinant adeno-associated virus-transfected dendritic cell vaccination in Chinese cancer patients

L. Che, Jun Ren, Yan-hua Yuan, 2012, Clinical and Translational Oncology.

Elevated level of peripheral CD8+CD28− T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy

Jiezhun Gu, H. Lyerly, Jun Ren, 2013, Cancer Immunology, Immunotherapy.

Non‐genetic risk factors and predicting efficacy for docetaxel–drug‐induced liver injury among metastatic breast cancer patients

Z. Wang, H. Lyerly, Jun Ren, 2012, Journal of gastroenterology and hepatology.

Clearance of Circulating Bacteria and Recovery of Microbiota Diversity Following Adoptive Cellular Therapy in Advanced Colorectal Cancer Patients

H. Lyerly, M. Morse, Jun Ren, 2020 .

Specific genetic polymorphisms of IL10-592 AA and IL10-819 TT genotypes lead to the key role for inducing docetaxel-induced liver injury in breast cancer patients

B. Shao, Z. Wang, H. Lyerly, 2013, Clinical and Translational Oncology.

The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion

H. Lyerly, M. Morse, Jun Ren, 2015, Oncotarget.

Breast Cancer Challenges and Screening in China: Lessons From Current Registry Data and Population Screening Studies.

Jun Ren, Hua-Bing Yang, H. Lyerly, 2015, The oncologist.

Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy

H. Lyerly, M. Morse, Jun Ren, 2021, Oncoimmunology.

Changes in peripheral blood regulatory T cells, and IL-6 and IL-10 levels predict response of pediatric medulloblastoma and germ cell tumors with residual or disseminated disease to craniospinal irradiation.

H. Lyerly, M. Morse, Linan Song, 2021, International journal of radiation oncology, biology, physics.

The prognostic values of CYP2B6 genetic polymorphisms and metastatic sites for advanced breast cancer patients treated with docetaxel and thiotepa

H. Kim Lyerly, Jun Ren, Jing Yu, 2015, Scientific Reports.

Continuous DC-CIK infusions restore CD8+ cellular immunity, physical activity and improve clinical efficacy in advanced cancer patients unresponsive to conventional treatments.

H. Lyerly, Lei Zhou, Jun Ren, 2015, Asian Pacific journal of cancer prevention : APJCP.

Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45)

X. Zhou, H. Lyerly, X. Wang, 2015, Clinical and Translational Oncology.